Humanigen Inc (HGENQ)
0.0001
0.00 (0.00%)
USD |
OTCM |
May 17, 09:30
Humanigen SG&A Expense (Quarterly): 3.719M for March 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
March 31, 2023 | 3.719M |
December 31, 2022 | 3.301M |
September 30, 2022 | 4.013M |
June 30, 2022 | 3.949M |
March 31, 2022 | 4.345M |
December 31, 2021 | 4.024M |
September 30, 2021 | 6.204M |
June 30, 2021 | 8.076M |
March 31, 2021 | 4.948M |
December 31, 2020 | 4.112M |
September 30, 2020 | 8.331M |
June 30, 2020 | 1.956M |
March 31, 2020 | 1.398M |
December 31, 2019 | 1.206M |
September 30, 2019 | 1.497M |
June 30, 2019 | 1.746M |
March 31, 2019 | 1.879M |
December 31, 2018 | 1.319M |
September 30, 2018 | 1.804M |
June 30, 2018 | 2.032M |
March 31, 2018 | 3.957M |
December 31, 2017 | 1.879M |
September 30, 2017 | 1.993M |
June 30, 2017 | 1.545M |
Date | Value |
---|---|
March 31, 2017 | 2.449M |
December 31, 2016 | 2.207M |
September 30, 2016 | 2.453M |
June 30, 2016 | 2.511M |
March 31, 2016 | 1.205M |
December 31, 2015 | 6.201M |
September 30, 2015 | 2.359M |
June 30, 2015 | 2.299M |
March 31, 2015 | 3.437M |
December 31, 2014 | 2.238M |
September 30, 2014 | 2.624M |
June 30, 2014 | 2.813M |
March 31, 2014 | 2.47M |
December 31, 2013 | 2.253M |
September 30, 2013 | 2.101M |
June 30, 2013 | 1.94M |
March 31, 2013 | 2.019M |
December 31, 2012 | 1.669M |
September 30, 2012 | 1.572M |
June 30, 2012 | 0.875M |
March 31, 2012 | 0.945M |
December 31, 2011 | 0.807M |
September 30, 2011 | 1.049M |
June 30, 2011 | 1.127M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
1.206M
Minimum
Dec 2019
8.331M
Maximum
Sep 2020
3.927M
Average
3.981M
Median
SG&A Expense (Quarterly) Benchmarks
Cannabis Global Inc | 0.3548M |
Item 9 Labs Corp | 3.354M |
Cantabio Pharmaceuticals Inc | 0.16M |
Affymax Inc | -- |
Statera BioPharma Inc | 1.738M |